More Characterization with Less Variation

Using the broadest selection of stem cell antibodies

  • From established stem cell markers to newly identified molecules
  • Manufactured & qualified in-house
  • Optimized for immunocytochemistry & flow cytometry

View available antibodies in your field

Detection of multiple potency markers increases confidence in results and decreases experimental variation. Small reductions in variability can unmask noisy data and reveal significant findings. R&D Systems manufactures over 12,000 high performance antibodies to facilitate thorough characterization of stem cell potency status and the signal transduction mechanisms that regulate differentiation and proliferation.

Learn more about our specialized kits for reducing experimental variation

Featured Data from our Recent Advertisement

Oct-4A (red) & E-Cadherin (green) in iPS2 human induced pluripotent stem cells. See Details

Oct-4A (red) & E-Cadherin (green) in iPS2 human induced pluripotent stem cells.

CD90/Thy1 & CD45 in human mesenchymal stem cells. See Details

CD90/Thy1 & CD45 in human mesenchymal stem cells.

SSEA-1 (red) & SSEA-4 (green) in live iPS2 human induced pluripotent stem cells.

SSEA-1 (red) & SSEA-4 (green) in live iPS2 human induced pluripotent stem cells.

Recent Publications Citing R&D Systems Featured Products for Definitive Endoderm Differentiation

  1. Ratcliffe, E. et al. (2013) Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture. Regen. Med. 8:39.
  2. Takemitsu, H. et al. (2012) Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells.
    BMC Vet. Res. 8:150.
  3. Azarin, SM. et al. (2012) Effects of 3D microwell culture on growth kinetics and metabolism of human embryonic stem cells.
    Biotech. & App. Biochem 59:88.
  4. Buchheiser, A. et al. (2012) Oxygen tension modifies the ‘stemness’ of human cord blood-derived stem cells.
    Cytotherapy 14:967.
  5. Giuliani, M. et al. (2011) Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation.
    PLoS One 6:e19988.

Related Information